3740 Total Publications
Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
Royse, SK, Minhas, DS, Lopresti, BJ, Murphy, A, Ward, T, Koeppe, RA, Bullich, S, DeSanti, S, Jagust, WJ and Landau, SM
2021; Journal Alzheimer's Research & Therapy; vol. 13; no. 1; pp. 10-Jan;
Comparing data-driven and hypothesis-driven MRI-based predictors of cognitive impairment in individuals from the Atherosclerosis Risk in Communities (ARIC) study
Casanova, R, Hsu, FC, Barnard, RT, Anderson, AM, Talluri, R, Whitlow, CT, Hughes, TM, Griswold, M, Hayden, KM, Gottesman, RF, Wagenknecht, LE and Alzheimer's Dis Neuroimaging, I
2021; Journal Alzheimers & Dementia; vol. 11;
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Hong, SJ, Dobricic, V, Ohlei, O, Bos, I, Vos, SJB, Prokopenko, D, Tijms, BM, Andreasson, U, Blennow, K, Vandenberghe, R, Gabel, S, Scheltens, P, Teunissen, CE, Engelborghs, S, Frisoni, G, Blin, O, Richardson, JC, Bordet, R, Lleo, A, Alcolea, D, Popp, J, Clark, C, Peyratout, G, Martinez-Lage, P, Tainta, M, Dobson, RJB, Legido-Quigley, C, Sleegers, K, Van Broeckhoven, C, Tanzi, RE, ten Kate, M, Wittig, M, Franke, A, Lill, CM, Barkhof, F, Lovestone, S, Streffer, J, Zetterberg, H, Visser, PJ, Bertram, L and Neuroimaging, I
2021; Journal Alzheimers & Dementia;
Personalized prediction of progression in pre-dementia patients based on individual biomarker profile: A development and validation study
Kühnel, L, Bouteloup, V, Lespinasse, J, Chêne, G, Dufouil, C, Molinuevo, JL and Raket, LL
2021; Journal Alzheimers Dement;
Higher cerebrospinal fluid tau is associated with history of traumatic brain injury and reduced processing speed in Vietnam-era veterans: A Department of Defense Alzheimer's Disease Neuroimaging Initiative (DOD-ADNI) study
Clark, AL, Weigand, AJ, Bangen, KJ, Thomas, KR, Eglit, GML, Bondi, MW and Delano-Wood, L
PMCID:8515227
; 2021; Journal Alzheimers Dement (Amst); vol. 13; no. 1; pp. e12239;
Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
Biel, D, Brendel, M, Rubinski, A, Buerger, K, Janowitz, D, Dichgans, M and Franzmeier, N
PMID: 34384484
; 2021; Journal Alzheimers Res Ther; vol. 13; no. 1; pp. 137;
Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer's disease
Dyrba, M, Hanzig, M, Altenstein, S, Bader, S, Ballarini, T, Brosseron, F, Buerger, K, Cantré, D, Dechent, P, Dobisch, L, Düzel, E, Ewers, M, Fliessbach, K, Glanz, W, Haynes, JD, Heneka, MT, Janowitz, D, Keles, DB, Kilimann, I, Laske, C, Maier, F, Metzger, CD, Munk, MH, Perneczky, R, Peters, O, Preis, L, Priller, J, Rauchmann, B, Roy, N, Scheffler, K, Schneider, A, Schott, BH, Spottke, A, Spruth, EJ, Weber, MA, Ertl-Wagner, B, Wagner, M, Wiltfang, J, Jessen, F and Teipel, SJ
2021; Journal Alzheimers Res Ther; vol. 13; no. 1; pp. 191;
Tetrahedral spectral feature-Based bayesian manifold learning for grey matter morphometry: Findings from the Alzheimer's disease neuroimaging initiative
Fan, Y, Wang, G, Dong, Q, Liu, Y, Leporé, N and Wang, Y
PMCID:8316398
; 2021; Journal Med Image Anal; vol. 72; pp. 102123;
